Page 181 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GELMC
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• Provirus reactivation is impaired in HIV-1 infected individuals on treatment with da- satinib and antiretroviral therapy.
Biochem Pharmacol. 2021 Oct;192:114666. doi: 10.1016/j.bcp.2021.114666.
Vigón L, Martínez-Román P, Rodríguez-Mora S, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Sánchez-Conde M, Ambrosioni J, Cervero M, Wyen C, Hoffmann C, Miró JM, Alcamí J, Podzamczer D, García-Gutiérrez V, Martínez-Picado J, Briz V, Rosa López- Huertas M, Planelles V, Coiras M; Multidisciplinary Group of Study of HIV-1 Reservoir MGS- HIVRES .
• Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU.
Front Immunol. 2021 Sep 20;12:742631. doi: 10.3389/fimmu.2021.742631.
Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cer- vero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR .
• Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Mol Oncol. 2021 Sep;15(9):2273-84. doi: 10.1002/1878-0261.12921.
Andrés-Zayas C, Suárez-González J, Rodríguez-Macías G, Dorado N, Osorio S, Font P, Carbonell D, Chicano M, Muñiz P, Bastos M, Kwon M, Díez-Martín JL, Buño I, Martínez- Laperche C .
• Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study.
Leuk Lymphoma. 2021 Mar;62(3):739-42. doi: 10.1080/10428194.2020.1839649. Ottmann OG, Stegelmann F, Breccia M, Steegmann JL, Olavarría E, Aimone P, Lipton JH .
• Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice.
Blood Cancer J. 2021 Feb 9;11(2):16. doi: 10.1038/s41408-021-00420-8. García-Gutiérrez V, Luna A, Alonso-Domínguez JM, Estrada N, Boque C, Xicoy B, Giraldo P, Angona A, Álvarez-Larrán A, Sánchez-Guijo F, Ramírez MJ, Mora E, Vélez P, Rosell A, Colorado Araujo M, Cuevas B, Sagüés M, Cortes M, Encinas MP, Casado Montero LF, Mo- reno Vega M, Serrano L, Gómez V, García-Hernández C, Lakhwani S, Paz Coll A, de Paz R, Suarez-Varela S, Fernández-Ruiz A, Pérez López R, Ortiz-Fernández A, Jiménez-Velasco A, Steegmann-Olmedillas JL, Hernández-Boluda JC .
181